Earnings History Data for Korro Bio, Inc. (KRRO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Korro Bio, Inc.

Frequency Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on harnessing the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company's lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss. Frequency Therapeutics Inc. is headquartered in Woburn, Mass.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
13-08-2024 AH KRRO Korro Bio, Inc. 319.00 -2.43 -2.40 0.00 Korro Bio GAAP EPS of -$2.43 beats by $0.29
[8/14/2024 1:30 PM]
39.50 3.14 
(8.64%)
36.36 0.0 
(0.00%)
9.15 - 97.91 52,904 70,000 186
13-08-2024 ?? KRRO Korro Bio, Inc. 333.55 -2.43 -2.39 15.00 Korro Bio GAAP EPS of -$2.43 beats by $0.29
[8/14/2024 1:30 PM]
44.56 4.85 
(12.21%)
39.12 -0.59 
(-1.49%)
9.15 - 97.91 123,185 70,000 176
14-05-2024 AH KRRO Korro Bio, Inc. 409.00 -2.44 -2.36 0.00 Korro Bio reports Q1 GAAP EPS of -$2.44
[5/15/2024 10:47 AM]
52.69 2.64 
(5.27%)
49.96 -0.09 
(-0.18%)
9.15 - 97.91 30,928 30,000 1,164